Государственное Учреждение "Институт Геронтологии Им. Д.Ф. Чеботарева" Намн Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Геронтологии Им. Д.Ф. Чеботарева" Намн УкраиныfiledCriticalГосударственное Учреждение "Институт Геронтологии Им. Д.Ф. Чеботарева" Намн Украины
Priority to UAU201112987UpriorityCriticalpatent/UA70016U/en
Publication of UA70016UpublicationCriticalpatent/UA70016U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for correction of melatonin-forming epiphysis function in patients with hypertension comprises the daily blood pressure monitoring. Additionally, the average daily systolic blood pressure and diurnal index of average systolic blood pressure are determined and state of melatonin-forming epiphysis function is calculated by the formula and at values of melatonin-forming epiphysis function below the age norm - 9 µg - melatonin is administered at a dose of 3 mg at 9-00 p.m.
UAU201112987U2011-11-042011-11-04Method for correction of melatonin-forming epiphysis function in patients with hypertension
UA70016U
(en)
Antl-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
method for complex treatment of patients with renal parenchimal arterial hypertension taking into account genotype in the background of chronic pyelonephritis